Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders

BACKGROUNDS: Little clinical data is available on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients with muscular disorders (MDs). The immunogenicity of SARS-CoV-2 vaccines against MDs, in particular, remains unknown. Thus, this study aimed to confirm the immunogenicity and sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasai, Ryousuke, Funato, Michinori, Maruta, Kanako, Yasuda, Kunihiko, Minatsu, Hiroshi, Ito, Junji, Takahashi, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941142/
https://www.ncbi.nlm.nih.gov/pubmed/36825020
http://dx.doi.org/10.3389/fimmu.2023.1103196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941142/
https://www.ncbi.nlm.nih.gov/pubmed/36825020
http://dx.doi.org/10.3389/fimmu.2023.1103196

Ejemplares similares